Chevy Chase Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Chevy Chase Trust’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-614	Closed	-$37K	–	809
2019 Q4	$37K	Buy	+614	New	+$36.6K	﹤0.01%	892

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chevy Chase Trust's IONS Position: Q1 2020 in Review

Chevy Chase Trust sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 614 shares — an estimated $37K sold.

Chevy Chase Trust first reported a position in IONS in Q4 2019 and held it in 1 quarter. The position peaked at $37K in Q4 2019. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

Chevy Chase Trust reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Chevy Chase Trust sold 614 Ionis Pharmaceuticals shares in Q1 2020, an estimated $37K.
Chevy Chase Trust first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Chevy Chase Trust's Ionis Pharmaceuticals position peaked at $37K in Q4 2019.
362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Chevy Chase Trust's 13F filing for Q1 2020, filed 13 May 2020.